Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design

Nucleic acid packed within virus-like particles (VLPs) is shown to shape the immune response and to induce stronger B cell responses in different immunisation models. Here, using a VLP displaying the highly conserved extracellular domain of the M2 protein (M2e) from the influenza viruses as an antig...

Full description

Bibliographic Details
Main Authors: Ariane C. Gomes, E. S. Roesti, Aadil El-Turabi, Martin F. Bachmann
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/7/2/47
_version_ 1811183969902788608
author Ariane C. Gomes
E. S. Roesti
Aadil El-Turabi
Martin F. Bachmann
author_facet Ariane C. Gomes
E. S. Roesti
Aadil El-Turabi
Martin F. Bachmann
author_sort Ariane C. Gomes
collection DOAJ
description Nucleic acid packed within virus-like particles (VLPs) is shown to shape the immune response and to induce stronger B cell responses in different immunisation models. Here, using a VLP displaying the highly conserved extracellular domain of the M2 protein (M2e) from the influenza viruses as an antigen, we demonstrate that the type of RNA packaged into VLPs can alter the quality of the induced humoral response. By comparing prokaryotic RNA (pRNA), eukaryotic RNA (eRNA) and transfer RNA (tRNA), we find that pRNA induces the most protective IgG subclasses using a murine influenza model. We provide evidence that this process is predominantly dependent on endosomal Toll-like receptor (TLR7), and rule out a role for cytoplasmic mitochondrial antiviral signalling protein (MAVS) and its upstream retinoic acid-inducible gene-I-like receptors (RIG-I). Our findings provide considerations for the rational design of VLP-based vaccines and the immunomodulation exerted by TLR7 ligands packaged within the particles. Based on this work, we conclude that VLPs packing prokaryotic RNA must be preferred whenever a response dominated by IgG2 is desired, while eukaryotic RNA should be employed in order to induce a response dominated by IgG1.
first_indexed 2024-04-11T13:06:41Z
format Article
id doaj.art-028c9086cdf444bc86a0aa813dbed139
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-04-11T13:06:41Z
publishDate 2019-06-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-028c9086cdf444bc86a0aa813dbed1392022-12-22T04:22:43ZengMDPI AGVaccines2076-393X2019-06-01724710.3390/vaccines7020047vaccines7020047Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine DesignAriane C. Gomes0E. S. Roesti1Aadil El-Turabi2Martin F. Bachmann3The Jenner Institute, Oxford University, Oxford OX3 7BN, UKDepartment for BioMedical Research (DBMR), Inselspital, University of Bern, 3010 Bern, SwitzerlandThe Jenner Institute, Oxford University, Oxford OX3 7BN, UKThe Jenner Institute, Oxford University, Oxford OX3 7BN, UKNucleic acid packed within virus-like particles (VLPs) is shown to shape the immune response and to induce stronger B cell responses in different immunisation models. Here, using a VLP displaying the highly conserved extracellular domain of the M2 protein (M2e) from the influenza viruses as an antigen, we demonstrate that the type of RNA packaged into VLPs can alter the quality of the induced humoral response. By comparing prokaryotic RNA (pRNA), eukaryotic RNA (eRNA) and transfer RNA (tRNA), we find that pRNA induces the most protective IgG subclasses using a murine influenza model. We provide evidence that this process is predominantly dependent on endosomal Toll-like receptor (TLR7), and rule out a role for cytoplasmic mitochondrial antiviral signalling protein (MAVS) and its upstream retinoic acid-inducible gene-I-like receptors (RIG-I). Our findings provide considerations for the rational design of VLP-based vaccines and the immunomodulation exerted by TLR7 ligands packaged within the particles. Based on this work, we conclude that VLPs packing prokaryotic RNA must be preferred whenever a response dominated by IgG2 is desired, while eukaryotic RNA should be employed in order to induce a response dominated by IgG1.https://www.mdpi.com/2076-393X/7/2/47VLPsRNATLR7IgG
spellingShingle Ariane C. Gomes
E. S. Roesti
Aadil El-Turabi
Martin F. Bachmann
Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
Vaccines
VLPs
RNA
TLR7
IgG
title Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
title_full Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
title_fullStr Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
title_full_unstemmed Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
title_short Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
title_sort type of rna packed in vlps impacts igg class switching implications for an influenza vaccine design
topic VLPs
RNA
TLR7
IgG
url https://www.mdpi.com/2076-393X/7/2/47
work_keys_str_mv AT arianecgomes typeofrnapackedinvlpsimpactsiggclassswitchingimplicationsforaninfluenzavaccinedesign
AT esroesti typeofrnapackedinvlpsimpactsiggclassswitchingimplicationsforaninfluenzavaccinedesign
AT aadilelturabi typeofrnapackedinvlpsimpactsiggclassswitchingimplicationsforaninfluenzavaccinedesign
AT martinfbachmann typeofrnapackedinvlpsimpactsiggclassswitchingimplicationsforaninfluenzavaccinedesign